BioVie Inc is a company developing innovative drug therapies to treat chronic debilitating conditions including liver disease and neurological and neuro-. Get the latest BioVie Inc (BIVI) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and. BioVie is a purpose-based company. Creating new solutions for Alzheimer's Stock Price · Our Team · Contact. Home. Through innovation, collaboration, and. View BioVie Inc. Class A BIVI stock quote prices, financial information, real-time forecasts, and company news from CNN. Based on 1 Wall Street analysts offering 12 month price targets for BioVie in the last 3 months. The average price target is $ with a high forecast of.
Why Shares of BioVie Jumped % in February. The company is forging ahead with a phase 3 trial for its lead therapy. Jim Halley |. See the latest BioVie Inc Ordinary Shares - Class A stock price (BIVI:XNAS), related news, valuation, dividends and more to help you make your investing. BioVie shares soar 19% premarket after company announces positive results from Phase 2 trial of Alzheimer's treatment. BioVie Inc. shares rose 19% in. In depth view into BIVI (BioVie) stock including the latest price, news, dividend history, earnings information and financials. Key Stock Data · P/E Ratio (TTM). N/A · EPS (TTM). $ · Market Cap. $ M · Shares Outstanding. M · Public Float. M · Yield. BIVI is not. View the BIVI premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Biovie Inc real time. Discover real-time BioVie Inc. Class A Common Stock (BIVI) stock prices, quotes, historical data, news, and Insights for informed trading and investment. Analyst's Opinion. Consensus Rating. BioVie has received a consensus rating of Moderate Buy. The company's average rating score is , and is based on 2 buy. BIVI - BioVie Inc - Stock screener for investors and traders, financial visualizations. Track BioVie Inc (BIVI) Stock Price, Quote, latest community messages, chart, news and other stock related information BIVI BioVie Inc. 2, $ $ BioVie Inc. (kraeved48.ru): Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock BioVie Inc. | Nasdaq: BIVI | Nasdaq.
BioVie Inc. is currently listed on NASDAQ under BIVI. One share of BIVI stock can currently be purchased for approximately $ Is. Stock Price for BioVie Inc. (BIVI) - Current price and chart of BIVI on NASDAQ Capital Market. BioVie, Inc. is a development stage biopharmaceutical company, which discovers, develops, and commercializes drug therapies for liver disease. View BioVie (BIVI) stock price, news, historical charts, analyst ratings, financial information and quotes on Moomoo. Trade commission-free with the Moomoo. The current price of BIVI is USD — it has decreased by −% in the past 24 hours. Watch BioVie Inc. stock price performance more closely on the chart. BIVI - BioVie Inc - Stock screener for investors and traders, financial visualizations. Volume, K. Market Value, $M. Shares Outstanding, M. EPS (TTM), -$ P/E Ratio (TTM), N/A. Dividend Yield, N/A. Latest Dividend, N/A. The BioVie Inc stock price gained % on the last trading day (Thursday, 29th Aug ), rising from $ to $ During the last trading day the stock. BioVie Inc. (US:BIVI) has institutional owners and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These.
View BioVie (BIVI) stock price, news, historical charts, analyst ratings, financial information and quotes on Moomoo. Trade commission-free with the Moomoo. BioVie Inc BIVI:NASDAQ · Open · Day High · Day Low · Prev Close · 52 Week High · 52 Week High Date11/22/23 · 52 Week Low · 52 Week Low. Looking to buy BioVie Inc Stock? View today's BIVI stock price, trade commission-free, and discuss BIVI stock updates with the investor community. The latest BioVie stock prices, stock quotes, news, and BIVI history to help you invest and trade smarter. Why Shares of BioVie Jumped % in February. The company is forging ahead with a phase 3 trial for its lead therapy. Jim Halley |.
(NASDAQ: BIVI) has announced the implementation of a 1-for reverse stock split of its issued and outstanding Class A common stock, effective August 6, BioVie Inc. stock grades by Barron's. View BIVI fundamental and sentiment analysis powered by MarketGrader. Biovie Inc stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. Looking to buy BioVie Inc Stock? View today's BIVI stock price, trade commission-free, and discuss BIVI stock updates with the investor community.
Year To Date Return Of The S&P 500 | Current Interest Rates For Student Loan Consolidation